Welcome to Gilga-Med.
New, safe and effective treatments for age-related diseases.
Death in old age is inevitable, but death before old age is not. ~Richard Doll
Our novel drug discovery platform is focused on producing small molecules that mimic the effects of dietary restrictions to increase protection against a wide range of age-related diseases.
Research & Discovery
Gilga-Med differs from other therapeutic development organizations in that its primary focus is directed toward age-related diseases as a class that bears similar pathophysiological mechanisms.
These mechanisms can be targeted by single small molecules.
Our platform is based on 30 years of research about mechanisms that link age with age-related diseases, including mechanisms that can delay the effects of age-related diseases when combined with dietary restriction.
Irreparable damage to a cell that is caused by an accumulation of impaired or misfolded proteins, impacting the heart and brain
Gilga-Med has identified over 50 novel compounds that delay age-related proteotoxicity in a C. elegans model of Alzheimer's disease.
Most compounds penetrated the brain at high concentrations after basic oral delivery!
Some of same compounds reduce proteotoxicity in a C. elegans model of Huntington's disease.